NovoCure Ltd. (NVCR)
12.97
-0.35
(-2.63%)
USD |
NASDAQ |
Dec 15, 16:00
12.89
-0.08
(-0.62%)
After-Hours: 20:00
NovoCure Cash from Investing (Quarterly): 71.44M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| LivaNova Plc | -23.06M |
| Perspective Therapeutics, Inc. | 13.99M |
| Xtant Medical Holdings, Inc. | 4.679M |
| VolitionRX Ltd. | 0.0012M |
| Catheter Precision, Inc. | -0.028M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 20.57M |
| Cash from Financing (Quarterly) | 100.52M |
| Free Cash Flow | -65.17M |
| Free Cash Flow Per Share (Quarterly) | 0.1333 |
| Free Cash Flow to Equity (Quarterly) | -82.77M |
| Free Cash Flow to Firm (Quarterly) | 14.92M |
| Free Cash Flow Yield | -4.54% |